Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Gross Profit: 2012-2024

Historic Gross Profit for Neurogene (NGNE) over the last 10 years, with Dec 2024 value amounting to $925,000.

  • Neurogene's Gross Profit fell 121.05% to -$42,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$610,000, marking a year-over-year increase of 47.91%. This contributed to the annual value of $925,000 for FY2024, which is 3403.57% up from last year.
  • Latest data reveals that Neurogene reported Gross Profit of $925,000 as of FY2024, which was up 3,403.57% from -$28,000 recorded in FY2023.
  • Neurogene's 5-year Gross Profit high stood at $925,000 for FY2024, and its period low was -$28,000 during FY2023.
  • Moreover, its 3-year median value for Gross Profit was -$7,000 (2022), whereas its average is $296,667.
  • In the last 5 years, Neurogene's Gross Profit tumbled by 300.00% in 2023 and then soared by 3,403.57% in 2024.
  • Neurogene's Gross Profit (Yearly) stood at -$7,000 in 2022, then plummeted by 300.00% to -$28,000 in 2023, then spiked by 3,403.57% to $925,000 in 2024.